Detection of EP2, EP4, and FP receptors in human ciliary epithelial and ciliary muscle cells

Biochemical Pharmacology

Volumn 53, Issue 9, 1997, Pages 1249-1255

  Mukhopadhyay, Partha ^a   Geoghegan, Thomas E ^c   Patil, Rajkumar V ^b   Bhattacherjee, Parimal ^a   Paterson, Christopher A ^a  

^a University of Louisville School of Medicine   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c NONE

Author keywords

Adenylyl cyclase; Ciliary muscle cells; Human nonpigmented ciliary epithelial cells; RT PCR

Indexed keywords

11 DEOXY 16 PHENOXY 17,18,19,20 TETRANORPROSTAGLANDIN E1; 7 [5 (4 BIPHENYLYLMETHOXY) 2 MORPHOLINO 3 OXOCYCLOPENTYL] 4 HEPTENOIC ACID; BUTAPROST; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; 11 DEOXYPROSTAGLANDIN E1; 11-DEOXYPROSTAGLANDIN E1; DRUG DERIVATIVE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E1; PROSTAGLANDIN E2 RECEPTOR, EP4 SUBTYPE; PROSTAGLANDIN F2ALPHA RECEPTOR;

ARTICLE; CELLULAR DISTRIBUTION; CILIARY BODY EPITHELIUM; CILIARY MUSCLE; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL CULTURE; CILIARY BODY; CLASSIFICATION; DOSE RESPONSE; EPITHELIUM; METABOLISM; PIGMENT EPITHELIUM;

ALPROSTADIL; CELLS, CULTURED; CILIARY BODY; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIUM; HUMANS; PIGMENT EPITHELIUM OF EYE; RECEPTORS, PROSTAGLANDIN; RECEPTORS, PROSTAGLANDIN E;

EID: 0030612520     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00011-7     Document Type: Article

References (45)

1. Kennedy I, Coleman RA, Humphrey PPA, Levy GP and Lumley P, Studies on the characterization of prostanoid receptors: A proposed classification. Prostaglandins 24: 667-689, 1982.
2. Coleman RA, Smith WL and Narumiya S, VIII International Union of Pharmacology Classification of Prostanoid Receptors: Properties, distribution and structure of the receptors and their subtypes. Pharmacol Rev 46: 205-229, 1994.
3. 2 receptor. Nature 349: 617-620, 1991.
4. Pierce KL, Gil DW, Woodward DR and Regan JW, Cloning of human prostanoid receptors. Trends Pharmacol Sci 16: 253-256, 1995.
5. 1 subtype of prostaglandin E receptor. J Biol Chem 268: 20175-20178, 1993.
6. 1 subtype. J Biol Chem 268: 26767-26772, 1993.
7. 2 subtype. J Biol Chem 268: 7759-7762, 1993.
8. 3 subtype. J Biol Chem 267: 6463-6466, 1992.
9. 3 subtype from human erythroleukaemia cells. Biochem J 298: 263-267, 1994.
10. 2α receptor. FEBS Lett 335: 317-325, 1994.
11. 2α from the ovine corpus luteum. Endocrinology 136: 3430-3436, 1995.
12. 3 receptors: Presence of three variants with differing carboxyl termini. Br J Pharmacol 112: 377-385, 1994.
13. Abramovitz M, Boie Y, Nguyen T, Rushmore TH, Baynes MA, Metters KM, Slipetz DM and Grygorczyk R, Cloning and expression of a cDNA for the human prostanoid FP receptor. J Biol Chem 269: 2632-2636, 1994.
14. Boie Y, Rushmore TH, Darmon-Goodwin A, Grygorczyk R, Slipetz DM, Metters KM and Abramovitz M, Cloning and expression of a cDNA for the human prostanoid IP receptor. J Biol Chem 269: 12173-12178, 1994.
15. Boie Y, Sawyer N, Slipetz DM, Metters KM and Abramovitz M, Molecular cloning and characterization of the human prostaglandin DP receptor. J Biol Chem 270: 18910-18916, 1995.
16. 2 subtype. J Biol Chem 270: 11873-11877, 1994.
17. 2 subtype. Mol Pharmacol 46: 213-220, 1994.
18. 2α lowers intraocular pressure. In: The Ocular Effects of Prostaglandins and Other Eicosanoids (Eds. Bito L and Stjernschantz J), pp. 387-416. Alan R. Liss, New York, 1989.
19. 2α in the human eye. Graefes Arch Clin Exp Ophthalmol 222: 139-141, 1985.
20. 2α-isopropyl ester eye drops: Effect on intraocular pressure in open angle glaucoma. Br J Ophthalmol 73: 975-979, 1989.
21. 2α and its isopropylester on normal and glaucomatous human eyes. In: The Ocular Effects of Prostaglandins and Other Eicosanoids (Eds. Bito L and Stjernschantz J), pp. 447-458. Alan R. Liss, New York, 1989.
22. Smithson M, Bhattacherjee P and Paterson CA, Prostanoid receptors and signal transduction in ciliary body and iris-sphincter muscle of cows, cats and humans. Invest Ophthalmol Vis Sci 36: S594, 1995.
23. Woodward DF, Lawrence RA, Fairbairn CE, Shan T and Williams LS, Intraocular pressure effects of selective prostanoid receptor agonists involve different receptor subtypes according to radioligand binding studies. J Lipid Med 6: 543-553, 1993.
24. 2 binding sites, distribution, and subtype classification in the rabbit iris-ciliary body. Prostaglandins 44: 199-208, 1992.
25. 2α binding sites in the bovine iris-ciliary body. Invest Ophthalmol Vis Sci 34: 2237-2245, 1993.
26. Bhattacherjee P, Rhodes L and Paterson CA, Prostaglandin receptors coupled to adenylate cyclase in the bovine iris-ciliary body of rabbits, cats, and cows. Exp Eye Res 56: 327-333, 1993.
27. Bhattacherjee P, Jacobs N, Coca-Prados M and Paterson CA, Identification of prostanoid receptors in rabbit nonpigmented ciliary epithelial cells. Exp Eye Res 62: 491-498, 1996.
28. Liu L, Ekong E, Bhattacherjee P and Paterson CA, Comparative studies on prostanoid receptors in human non-pigmented ciliary epithelial and mouse fibroblast cell lines. Prostaglandins, Leuko Essent Fatty Acids 55: 231-240, 1996.
29. 2-receptor stimulated cyclic AMP synthesis in cultured human nonpigmented ciliary epithelium. Exp Eye Res 58: 563-566, 1994.
30. 2α on calcium efflux. Invest Ophthalmol Vis Sci 33: 2679-2886, 1992.
31. 2 receptor is the predominant receptor in the human ciliary muscle. Br J Ophthalmol 7: 110-114, 1993.
32. Coleman RA, Grix SP, Head SA, Louttit JB, Mallett A and Sheldrick RLG, A novel inhibitory receptor in piglet saphenous vein. Prostaglandins 47: 151-168, 1994.
33. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ, Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
34. Chomczynski P and Sacchi N, Single-step RNA isolation from cultured cells or tissues. In: Current Protocol in Molecular Biology (Eds. Ausubel FA, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K), pp. 4.2.4-4.2.8. John Wiley, New York, 1989.
35. 2 receptor subtype. Invest Ophthalmol Vis Sci 31: 2463-2466, 1990.
36. 1 on exudative and tissue components of granulomatous inflammation in rats. Br J Pharmacol 65: 465-472, 1979.
37. 2 elevation of cyclic-AMP in granuloma macrophages at various stages of inflammation: Relevance to anti-inflammatory and immunomodulatory functions. Prostaglandins 22: 95-103, 1981.
38. Bhattacherjee P, The role of arachidonate metabolites in ocular inflammation. In: The Ocular Effects of Prostaglandins and Other Eicosanoids (Eds. Bito L and Stjernschantz J), pp. 221-227. Alan R. Liss, New York, 1989.
39. 2 in perfused rat lungs injured with hydrogen peroxide. J Pharmacol Exp Ther 241: 1-5, 1987.
40. Wong KL and Howes EL, Intraocular injection of prostaglandins. Modification of response to circulating bacterial endotoxin. Arch Ophthalmol 101: 275-279, 1983.
41. Goldyne ME and Stobo JD, Immunoregulatory role of prostaglandins and related lipids. CRC Crit Rev Immunol 2: 189-223, 1981.
42. Goodwin JS and Ceuppens J, Regulations of the immune response by prostaglandins. J Clin Immunol 3: 295-315, 1993.
43. Ninnemann JL, Monocytes and macrophages. In: Prostaglandins, Leukotrienes and the Immune Response (Ed. Ninnemann JL), pp. 34-52, Cambridge University Press, Cambridge, 1988.
44. Camras CB, Schumar RA, Marsk A, Lustgurten JS, Serle JB and Stjernschantz J, Intraocular pressure reduction with PhXA34, a new prostaglandin analogue, in patients with ocular hypertension. Arch Ophthalmol 110: 1733-1738, 1992.
45. Goh Y, Hotehama Y and Mishima H, Characterization of ciliary muscle relaxation induced by various agents in cats. Invest Ophthalmol Vis Sci 36: 1188-1192, 1995.